Strengthening the clinical leadership as the Company progresses to the clinic with its BRD9 Targeted Glue™, AMX-883, in acute myeloid leukemiaAmphista continues to advance its SMARCA and TEAD programs ...
Amphista Therapeutics has appointed Louise Modis as CEO to succeed Antony Mattessich, who is retiring, and the highly ...
Intel (NASDAQ: INTC) stock has nearly doubled over the past year, gaining 91.46% to a current price of $46.18. Its 22.9% YTD gain that sharply outpaces the Nasdaq’s −6.2% YTD return. Yet analyst ...
The 1968 AMC AMX stands as one of the most audacious gambles in automotive history. While the “Big Three” (Ford, GM, and ...
Birmingham, Alabama, hosts the first East / West Showdown of the 2026 season.
The CBS Sports 2026 NCAA Men's and Women's Games have returned for March Madness 2026 office pools.
A UK-based biotechnology company developing next-generation targeted protein degradation (TPD) therapies. Amphista Therapeutics focuses on rationally designed “targeted glue” molecules that harness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results